Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice

Cytokine

Volumn 56, Issue 2, 2011, Pages 256-264

  Mirza, Rita ^a   Koh, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cytokines; Diabetes; Growth factors; Macrophage; Wound healing

Indexed keywords

CD206 ANTIGEN; CD36 ANTIGEN; COLLAGEN; GAMMA INTERFERON; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LYMPHOCYTE ANTIGEN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; GRANULATION TISSUE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

ANIMALS; BASE SEQUENCE; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; MACROPHAGES; MICE; MONOCYTES; POLYMERASE CHAIN REACTION; WOUND HEALING; WOUNDS AND INJURIES;

MUS;

EID: 80053300866     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.016     Document Type: Article

References (40)

1. Sen C.K., Gordillo G.M., Roy S., Kirsner R., Lambert L., Hunt T.K., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009, 17:763-771.
2. White R., McIntosh C. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: advanced treatments. J Wound Care 2009, 18:335-341.
3. White R., McIntosh C. Topical therapies for diabetic foot ulcers: standard treatments. J Wound Care 2008, 17(426):428-432.
4. Woo K., Ayello E.A., Sibbald R.G. The edge effect: current therapeutic options to advance the wound edge. Adv Skin Wound Care 2007, 20:99-117. [quiz 118-9].
5. Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998, 111:850-857.
6. Mast B.A., Schultz G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996, 4:411-420.
7. Rosner K., Ross C., Karlsmark T., Petersen A.A., Gottrup F., Vejlsgaard G.L. Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers. Apmis 1995, 103:293-299.
8. Trengove N.J., Bielefeldt-Ohmann H., Stacey M.C. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000, 8:13-25.
9. Goren I., Allmann N., Yogev N., Schurmann C., Linke A., Holdener M., et al. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 2009, 175:132-147.
10. Leibovich S.J., Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975, 78:71-100.
11. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184:3964-3977.
12. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454-2462.
13. Blakytny R., Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006, 23:594-608.
14. Goren I., Kampfer H., Podda M., Pfeilschifter J., Frank S. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 2003, 52:2821-2832.
15. Greenhalgh D.G., Sprugel K.H., Murray M.J., Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990, 136:1235-1246.
16. Khanna S., Biswas S., Shang Y., Collard E., Azad A., Kauh C., et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 2010, 5:e9539.
17. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
18. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
19. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Ann Rev Immunol 2009, 27:451-483.
20. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
21. Daley J.M., Brancato S.K., Thomay A.A., Reichner J.S., Albina J.E. The phenotype of murine wound macrophages. J Leukoc Biol 2010, 87:59-67.
22. Sindrilaru A., Peters T., Wieschalka S., Baican C., Baican A., Peter H., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011, 121:985-997.
23. Galkina E., Kadl A., Sanders J., Varughese D., Sarembock I.J., Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006, 203:1273-1282.
24. Hirsch S., Austyn J.M., Gordon S. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 1981, 154:713-725.
25. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
26. Trengove N.J., Langton S.R., Stacey M.C. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996, 4:234-239.
27. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002, 45:1011-1016.
28. Wetzler C., Kampfer H., Stallmeyer B., Pfeilschifter J., Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115:245-253.
29. Rodgers K.E., Ellefson D.D., Espinoza T., Hsu Y.H., diZerega G.S., Mehrian-Shai R. Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury. Wound Repair Regen 2006, 14:298-305.
30. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
31. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047.
32. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069.
33. Dewals B.G., Marillier R.G., Hoving J.C., Leeto M., Schwegmann A., Brombacher F. IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl Trop Dis 2010, 4:e689.
34. Fadok V.A., McDonald P.P., Bratton D.L., Henson P.M. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans 1998, 26:653-656.
35. Ren Y., Savill J. Apoptosis: the importance of being eaten. Cell Death Differ 1998, 5:563-568.
36. Cvetanovic M., Ucker D.S. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol 2004, 172:880-889.
37. Lucas M., Stuart L.M., Zhang A., Hodivala-Dilke K., Febbraio M., Silverstein R., et al. Requirements for apoptotic cell contact in regulation of macrophage responses. J Immunol 2006, 177:4047-4054.
38. Fadok V.A., Warner M.L., Bratton D.L., Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 1998, 161:6250-6257.
39. Greenberg M.E., Sun M., Zhang R., Febbraio M., Silverstein R., Hazen S.L. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 2006, 203:2613-2625.
40. Goren I., Muller E., Schiefelbein D., Christen U., Pfeilschifter J., Muhl H., et al. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007, 127:2259-2267.